Mechanical stress shapes the cancer cell response to neddylation inhibition
Abstract Background The inhibition of neddylation by the preclinical drug MLN4924 represents a new strategy to combat cancer. However, despite being effective against hematologic malignancies, its success in solid tumors, where cell–cell and cell-ECM interactions play essential roles, remains elusiv...
Main Authors: | Frédérique Mittler, Patricia Obeïd, Vincent Haguet, Cédric Allier, Sophie Gerbaud, Anastasia V. Rulina, Xavier Gidrol, Maxim Y. Balakirev |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-022-02328-y |
Similar Items
-
High-Content Monitoring of Drug Effects in a 3D Spheroid Model
by: Frédérique Mittler, et al.
Published: (2017-12-01) -
Correction: Mechanical stress shapes the cancer cell response to neddylation inhibition
by: Frédérique Mittler, et al.
Published: (2022-05-01) -
Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin
by: Shanshan Gu, et al.
Published: (2023-09-01) -
Neddylation regulation of mitochondrial structure and functions
by: Qiyin Zhou, et al.
Published: (2021-03-01) -
Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1
by: Hongmei Mao, et al.
Published: (2019-03-01)